US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.090
- +0.010+0.93%
Close Oct 16 16:00 ET
- 1.110
- +0.020+1.83%
Post 19:06 ET
80.16MMarket Cap-6055P/E (TTM)
1.110High1.070Low125.28KVolume1.100Open1.080Pre Close136.73KTurnover0.23%Turnover Ratio12.11P/E (Static)73.54MShares1.90052wk High2.80P/B59.57MFloat Cap0.82152wk Low--Dividend TTM54.65MShs Float1037.500Historical High--Div YieldTTM3.70%Amplitude0.700Historical Low1.091Avg Price1Lot Size
Protalix Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M | 24.22%47.64M | 0.80%8.62M | 17.66%14.18M |
| Operating revenue | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M | 24.22%47.64M | 0.80%8.62M | 17.66%14.18M |
| Cost of revenue | 53.81%9.46M | -15.66%2.6M | 17.30%22.98M | 269.46%8.86M | -30.83%4.89M | 50.43%6.15M | -48.87%3.09M | 19.84%19.59M | -23.86%2.4M | 91.03%7.07M |
| Gross profit | -86.11%4.02M | -82.38%1.15M | 51.58%42.51M | -73.79%1.63M | -23.31%5.45M | 519.95%28.93M | -35.30%6.5M | 27.48%28.05M | 15.16%6.22M | -14.87%7.11M |
| Operating expense | -24.23%6.45M | -33.03%6M | -21.94%32.05M | -16.87%7.25M | -28.29%7.34M | -16.53%8.51M | -24.82%8.96M | -3.30%41.06M | -21.54%8.72M | -0.02%10.23M |
| Selling and administrative expenses | -13.57%3.48M | 0.00%3.12M | 27.73%14.96M | 33.73%4.14M | 28.86%3.67M | 54.39%4.03M | -1.24%3.12M | -8.00%11.71M | -10.62%3.1M | -3.59%2.85M |
| Research and development costs | -33.83%2.96M | -50.62%2.89M | -41.76%17.09M | -44.77%3.1M | -50.32%3.67M | -40.96%4.48M | -33.31%5.85M | -1.29%29.35M | -26.49%5.62M | 1.43%7.39M |
| Operating profit | -111.88%-2.43M | -97.48%-4.86M | 180.37%10.46M | -125.05%-5.62M | 39.62%-1.89M | 469.68%20.42M | -31.50%-2.46M | 36.40%-13.01M | 56.27%-2.5M | -65.78%-3.13M |
| Net non-operating interest income expense | 120.03%155K | 125.79%123K | -36.95%-1.89M | -13.43%-811K | 138.01%168K | -507.37%-774K | -14.66%-477K | 80.58%-1.38M | 21.43%-715K | 80.90%-442K |
| Non-operating interest income | -1.69%522K | 198.26%513K | 12.22%1.29M | 43.08%-37K | 218.78%628K | -34.69%531K | -14.85%172K | 185.79%1.15M | -3,150.00%-65K | 105.21%197K |
| Non-operating interest expense | -71.88%367K | -39.91%390K | 25.74%3.18M | 19.08%774K | -28.01%460K | 109.47%1.31M | 5.02%649K | -66.37%2.53M | -28.41%650K | -73.49%639K |
| Other net income (expense) | ||||||||||
| Income before tax | -111.56%-2.27M | -61.21%-4.73M | 159.50%8.57M | -100.19%-6.43M | 51.81%-1.72M | 468.34%19.65M | -28.43%-2.94M | 47.80%-14.4M | 51.85%-3.21M | 15.05%-3.57M |
| Income tax | -122.40%-69K | -170.77%-138K | -52.08%254K | -172.08%-382K | 133K | 308K | 195K | 530K | 530K | 0 |
| Net income | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M | 15.05%-3.57M |
| Net income continuous Operations | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M | 15.05%-3.57M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M | 15.05%-3.57M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M | 15.05%-3.57M |
| Basic earnings per share | -110.34%-0.03 | -20.00%-0.06 | 138.71%0.12 | -42.86%-0.1 | 57.14%-0.03 | 363.64%0.29 | 0.00%-0.05 | 50.00%-0.31 | 50.00%-0.07 | 22.22%-0.07 |
| Diluted earnings per share | -114.29%-0.03 | -20.00%-0.06 | 129.03%0.09 | -42.86%-0.1 | 42.86%-0.04 | 290.91%0.21 | 0.00%-0.05 | 50.00%-0.31 | 50.00%-0.07 | 22.22%-0.07 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data